Syngene International

Sector: Healthcare

Followers

0
0
2
2
.
6
6
3
3
6
6
-3.60 (-0.56%)

As on 08 Dec, 2025 | 09:17

Open Trading A/c
Day Range
635.00
638.00
LH
52 Week Range
599.55
917.95
LH
Volume
* i
Bid / Ask
3,164.00
635.80 / 11.00

Syngene International Announcements

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find the details of the meeting to be held with...

27 Nov, 2025 | 05:43pm • Source: BSE

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find the details of the meeting to be held with...

24 Nov, 2025 | 11:50pm • Source: BSE

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find the details of the meeting to be held with...

17 Nov, 2025 | 04:38pm • Source: BSE

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find the details of the meeting to be held with...

14 Nov, 2025 | 03:30pm • Source: BSE

Intimation of Earnings call transcript for Q2 FY2026

12 Nov, 2025 | 08:14pm • Source: BSE

Intimation of Earnings call transcript for Q2 FY2026

12 Nov, 2025 | 08:14pm • Source: BSE

Advertisement in Newspapers - Financial Results

07 Nov, 2025 | 07:00pm • Source: BSE

Intimation of audio recording for Q2 FY26 post-earnings call

06 Nov, 2025 | 07:00pm • Source: BSE

Syngene International Limited has informed the Exchange about Investor Presentation

06 Nov, 2025 | 01:24pm • Source: NSE

Investor Presentation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

06 Nov, 2025 | 01:13pm • Source: BSE

Outcome of the Board Meeting - November 05, 2025.

05 Nov, 2025 | 08:56pm • Source: BSE

Press Release dated November 05, 2025.

05 Nov, 2025 | 08:48pm • Source: BSE

Unaudited financial results for the quarter & half year ended September 30, 2025

05 Nov, 2025 | 08:44pm • Source: BSE

Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

04 Nov, 2025 | 05:48pm • Source: BSE

Intimation of Conference Call for Analysts and Investors.

31 Oct, 2025 | 09:36pm • Source: BSE

Appointment of Mr. Surender Sharma as General Counsel and a member of the Executive Committee (Senior Management Personnel) of the Company w.e.f. October 28, 2025.

28 Oct, 2025 | 04:24pm • Source: BSE

The Exchange has sought clarification from Syngene International Limited with respect to recent news item captioned Syngene expands Biologics facility with new ADC bioconjugation capability....

24 Oct, 2025 | 03:18pm • Source: NSE

Email communication to shareholders under 100 Days Campaign - "Saksham Niveshak"

18 Oct, 2025 | 09:15pm • Source: BSE

Newspaper Advertisement - Notice to shareholders 100-day Campaign - Saksham Niveshak

14 Oct, 2025 | 05:19pm • Source: BSE

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

09 Oct, 2025 | 06:16pm • Source: BSE